This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove partnerships-are-driving-global-covid-19-treatment-access
Remove Blog Related Topics
Omnicell Sterile Compounds Medication Dispensing Customer Service Patient Care Inventory Control Documentation Communication Controlled Substances Scheduling Appointments More Related Topics >
article thumbnail

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward

ISPE

NOVEMBER 2, 2022

iSpeak Blog. Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Vice President, Hospital Business Unit Global Supply Chain. Trudy Patterson.

Vaccines 98
Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98
article thumbnail

2022 ISPE Annual Meeting: Convergence and Harmonization Support New Therapies

ISPE

NOVEMBER 3, 2022

iSpeak Blog. There is also opportunity for regulators to continue to share information through convergence that may make it possible to provide new therapies on a more global basis. He presented on “The Potential Impact of Global Convergence on the Availability of Cell and Gene Therapy.” Trudy Patterson. Susan Sandler.

Communication 98
Communication FDA Documentation Vaccines 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024